US WorldMeds Employee Directory
Pharmaceutical ManufacturingKentucky, United States51-200 Employees
US WorldMeds is a specialty pharmaceutical company based in Louisville, Kentucky, that develops, licenses, and brings to market medicines intended to help patients with challenging conditions and unmet medical needs. It is privately held and was organized on March 23, 2001 by current CEO Paul Breckinridge 'Breck' Jones, reflecting a focus on agility and close attention to its products and stakeholders. The company pursues a multi-therapeutic portfolio and ongoing development to bring new therapies and indications to patients, supported by a culture that emphasizes honesty, creativity, action, integrity in relationships, and prudent stewardship of resources. Headquartered in Louisville, US WorldMeds operates with teams and partners across the United States and globally. It sits within the pharmaceutical manufacturing industry as a nimble, specialty-focused player delivering patient-centered medicines. In 2022, the company, in partnership with Adamis Pharmaceuticals, launched ZIMHI—a high-dose naloxone injectable for emergency treatment of opioid overdose—marking a notable addition to its product offerings.